A new class of startups is taking hold in Cambridge — and unlike the life sciences firms that the city built its wealth on, they’re not making cancer treatments or testing novel vaccines. Instead, ...

Altman said OpenAI rushed its deal with the Defense Department and moved to revise the terms. The company said its tools would not be used by intelligence agencies, among other tweaks. The agreement ...